Hendley & Co. Inc. Sells 2,046 Shares of Stryker Corporation $SYK

Hendley & Co. Inc. lowered its stake in shares of Stryker Corporation (NYSE:SYK) by 12.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,288 shares of the medical technology company’s stock after selling 2,046 shares during the quarter. Stryker accounts for 1.8% of Hendley & Co. Inc.’s investment portfolio, making the stock its 21st largest holding. Hendley & Co. Inc.’s holdings in Stryker were worth $5,022,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also bought and sold shares of SYK. United Financial Planning Group LLC bought a new stake in Stryker during the third quarter worth $27,000. CGC Financial Services LLC bought a new stake in Stryker during the fourth quarter worth $29,000. Strive Asset Management LLC bought a new stake in Stryker during the third quarter worth $30,000. ANTIPODES PARTNERS Ltd bought a new stake in Stryker during the third quarter worth $34,000. Finally, Copia Wealth Management grew its holdings in Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock worth $40,000 after buying an additional 69 shares in the last quarter. Institutional investors own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

SYK has been the subject of several recent research reports. Robert W. Baird set a $385.00 price target on Stryker in a report on Friday, May 1st. Canaccord Genuity Group decreased their price target on Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Barclays decreased their price target on Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. BTIG Research decreased their price target on Stryker from $397.00 to $379.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Finally, Citigroup decreased their price target on Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research report on Tuesday, April 7th. Sixteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Insider Transactions at Stryker

In other Stryker news, VP M Kathryn Fink sold 3,500 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.45, for a total value of $992,075.00. Following the completion of the sale, the vice president directly owned 177 shares of the company’s stock, valued at $50,170.65. This trade represents a 95.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 4.60% of the stock is owned by corporate insiders.

Stryker Stock Performance

NYSE:SYK opened at $306.74 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The business has a fifty day simple moving average of $329.68 and a two-hundred day simple moving average of $351.73. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $404.87. The company has a market capitalization of $117.59 billion, a P/E ratio of 35.50, a P/E/G ratio of 1.93 and a beta of 0.80.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. During the same period in the prior year, the business earned $2.84 earnings per share. The business’s quarterly revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, analysts expect that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.